XML 26 R8.htm IDEA: XBRL DOCUMENT v3.23.3Close
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:      
Net income $ 1,739 $ 1,509 $ 1,403
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:      
Depreciation and amortization 165 145 134
Deferred income taxes, net (88) (16) (37)
Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gain/loss on other investments (49) 23 15
Provisions/(benefits) for credit losses and legal and regulatory proceedings 292 111 (20)
Share-based compensation expense 237 192 132
Unrealized (gain)/loss on company-owned life insurance policies, net of expenses (96) 174 (150)
Losses on extinguishment of debt 0 0 98
Other 10 49 66
Net change in:      
Assets segregated for regulatory purposes excluding cash and cash equivalents 0 2,100 (2,100)
Collateralized agreements, net of collateralized financings 157 (37) (29)
Loans (provided to) financial advisors, net of repayments (7) (120) (90)
Brokerage client receivables and other receivables, net 257 (203) (420)
Trading instruments, net (33) 48 (141)
Derivative instruments, net (130) 479 53
Other assets (52) (126) 16
Brokerage client payables and other payables (6,088) (4,213) 7,306
Accrued compensation, commissions and benefits 123 (76) 416
Purchases and originations of loans held for sale, net of proceeds from sales of securitizations and loans held for sale 49 33 (5)
Net cash provided by/(used in) operating activities (3,514) 72 6,647 Close
Cash flows from investing activities:      
Increase in bank loans, net (1,262) (7,235) (4,027)
Proceeds from sales of loans held for investment 680 213 287
Purchases of available-for-sale securities (611) (3,069) (4,218)
Available-for-sale securities maturations, repayments and redemptions 1,262 1,712 2,181
Proceeds from sales of available-for-sale securities 0 52 969
Cash and cash equivalents acquired in business acquisitions, including those segregated for regulatory purposes, net of cash paid for acquisitions 0 1,461 (266)
Additions to property and equipment (173) (91) (74)
Purchase of Federal Reserve Bank stock (22) 0 0
Purchases of Federal Home Loan Bank stock, net (4) 0 0
Investment in note receivable 0 (125) 0
Investment in solar tax credit equity investment (69) 0 0
(Purchases)/sales of other investments, net (6) 24 27
Other investing activities, net (69) (93) (19)
Net cash used in investing activities (274) (7,151) (5,140) Close
Cash flows from financing activities:      
Proceeds from senior notes issuances, net of debt issuance costs paid 0 0 737
Extinguishment of senior notes payable 0 0 (844)
Increase in bank deposits 2,842 6,269 5,694
Repurchases of common stock and share-based awards withheld for payment of withholding tax requirements (862) (216) (150)
Dividends on common and preferred stock (355) (277) (218)
Redemption of preferred stock (40) 0 0
Exercise of stock options and employee stock purchases 46 52 53
Proceeds from Federal Home Loan Bank advances 3,200 1,025 0
Repayments of Federal Home Loan Bank advances and other borrowed funds (3,391) (967) (31)
Other financing, net (2) (7) (9)
Net cash provided by financing activities 1,438 5,879 5,232 Close
Currency adjustment:      
Effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes 239 (590) 76 Close
Net increase/(decrease) in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash (2,111) (1,790) 6,815 Close
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year 14,659 16,449 9,634
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of year 12,548 14,659 16,449
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]      
Cash and cash equivalents 9,313 6,178 7,201
Cash and cash equivalents segregated for regulatory purposes and restricted cash 3,235 8,481 9,248
Total cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of year 12,548 14,659 16,449
Supplemental disclosures of cash flow information:      
Cash paid for interest 1,310 323 145
Cash paid for income taxes, net 565 524 437
Cash outflows for lease liabilities 123 111 110
Non-cash right-of-use assets recorded for new and modified leases 143 68 168
Restricted stock awards issued as consideration for TriState Capital acquisition 0 28 0
Effective settlement of note receivable for TriState Capital acquisition 0 123 0
Common stock      
Supplemental disclosures of cash flow information:      
Stock issued as consideration for TriState Capital acquisition 0 778 0
Preferred stock      
Supplemental disclosures of cash flow information:      
Stock issued as consideration for TriState Capital acquisition $ 0 $ 120 $ 0